Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits

Published 2019 View Full Article

Authors

Keywords

Hormone replacement therapy, BRCA1, BRCA2, Surgical menopause, Breast cancer, Risk reduction

Journal

GYNECOLOGIC ONCOLOGY

Volume -, Issue -, Pages -

Publisher

Elsevier BV

Online

2019-01-18

DOI

10.1016/j.ygyno.2018.12.014

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started